日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection

接种疫苗的个体在发生 Delta/BA.1 突破性感染后会产生广泛而有效的中和抗体

Jeffrey Seow #, Zayed A Shalim #, Carl Graham, Simon Kimuda, Aswin Pillai, Thomas Lechmere, Ashwini Kurshan, Atika M Khimji, Luke B Snell, Gaia Nebbia, Christine Mant, Anele Waters, Julie Fox, Michael H Malim, Katie J Doores

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

ChAdOx1 nCoV-19疫苗可诱导产生对SARS-CoV-2病毒变种具有交叉中和活性的单克隆抗体

Jeffrey Seow ,Carl Graham ,Sadie R Hallett ,Thomas Lechmere ,Thomas J A Maguire ,Isabella Huettner ,Daniel Cox ,Hataf Khan ,Suzanne Pickering ,Rebekah Roberts ,Anele Waters ,Christopher C Ward ,Christine Mant ,Michael J Pitcher ,Jo Spencer ,Julie Fox ,Michael H Malim ,Katie J Doores

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

Omicron 突破性感染和延长 BNT162b2 加强剂量对关注的 SARS-CoV-2 变体中和广度的影响

Carl Graham, Thomas Lechmere, Aisha Rehman, Jeffrey Seow, Ashwini Kurshan, Isabella Huettner, Thomas J A Maguire, Jerry C H Tam, Daniel Cox, Christopher Ward, Mariusz Racz, Anele Waters, Christine Mant, Michael H Malim, Julie Fox, Katie J Doores

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals

在接种 COVID-19 疫苗的个体中,Delta 出现突破性感染后,包括 Omicron 在内的 SARS-CoV-2 变体被广泛中和

Thomas Lechmere #, Luke B Snell #, Carl Graham, Jeffrey Seow, Zayed A Shalim, Themoula Charalampous, Adela Alcolea-Medina, Rahul Batra, Gaia Nebbia, Jonathan D Edgeworth, Michael H Malim, Katie J Doores

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

SARS-CoV-2 及其相关变异株感染者恢复期血清中的中和抗体活性

Liane Dupont #, Luke B Snell #, Carl Graham #, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Thomas J A Maguire, Sadie R Hallett, Suzanne Pickering, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Jose M Jimenez-Guardeño, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E Dickenson, Rui

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia

单剂量 BNT162b2 mRNA 疫苗可对抗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2),在慢性粒细胞白血病患者中诱导中和抗体和多功能 T 细胞反应

Patrick Harrington, Katie J Doores, Deepti Radia, Amy O'Reilly, Ho Pui Jeff Lam, Jeffrey Seow, Carl Graham, Thomas Lechmere, Donal McLornan, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O'Sullivan, Kavita Raj, Shahram Kordasti,

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

SARS-CoV-2 第 1 波和 B.1.1.7 感染后的抗体寿命和交叉中和活性

Liane Dupont #, Luke B Snell #, Carl Graham #, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Sadie R Hallett, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Thomas J A Maguire, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E Dickenson, Rui Pedro Galao, Jose M Jimenez-Guardeño, Neoph